344860 — Innogene Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩26bn
- KR₩25bn
- KR₩10bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 472 | 717 | 2,818 | 3,198 | 1,307 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 753 | 781 | 1,011 | 1,066 | 995 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,429 | 2,648 | 5,065 | 6,216 | 15,476 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,829 | 1,635 | 1,519 | 1,445 | 1,412 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 4,411 | 4,390 | 6,668 | 7,949 | 17,200 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 920 | 1,157 | 1,176 | 1,175 | 1,144 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2,053 | 1,243 | 1,263 | 1,205 | 1,174 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2,357 | 3,147 | 5,405 | 6,744 | 16,026 |
Total Liabilities & Shareholders' Equity | 4,411 | 4,390 | 6,668 | 7,949 | 17,200 |
Total Common Shares Outstanding |